Effect of Donepezil on Wernicke Aphasia After Bilateral Middle Cerebral Artery Infarction: Subtraction Analysis of Brain F-18 Fluorodeoxyglucose Positron Emission Tomographic Images.

Abstract

Aphasia is one of the most common neurologic deficits occurring after stroke. Although the speech-language therapy is a mainstream option for poststroke aphasia, pharmacotherapy is recently being tried to modulate different neurotransmitter systems. However, the efficacy of those treatments is still controversial. We present a case of a 53-year-old female patient with Wernicke aphasia, after the old infarction in the territory of left middle cerebral artery for 8 years and the recent infarction in the right middle cerebral artery for 4 months. On the initial evaluation, the Aphasia Quotient in Korean version of the Western Aphasia Battery was 25.6 of 100. Baseline brain F-18 fluorodeoxyglucose positron emission tomographic images demonstrated a decreased cerebral metabolism in the left temporoparietal area and right temporal lobe. Donepezil hydrochloride, a reversible acetylcholinesterase inhibitor, was orally administered 5 mg/d for 6 weeks after the initial evaluation and was increased to 10 mg/d for the following 6 weeks. After the donepezil treatment, the patient showed improvement in language function, scoring 51.0 of 100 on Aphasia Quotient. A subtraction analysis of the brain F-18 fluorodeoxyglucose positron emission tomographic images after donepezil medication demonstrated increased uptake in both middle temporal gyri, extended to the occipital area and the left cerebellum. Thus, we suggest that donepezil can be an effective therapeutic choice for the treatment of Wernicke aphasia.

• Authors: Seo Yeon Yoon, Je-Kyung Kim, Young-Sil An, Yong Wook Kim
• Journal: Clinical neuropharmacology (Clin Neuropharmacol) 2015 Jul-Aug Vol. 38 Issue 4 Pg. 147-50 ISSN: 1537-162X [Electronic] United States
• PMID: 26166237 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Indans
• Nootropic Agents
• Piperidines
• Fluorodeoxyglucose F18
• Donepezil

Topics

• Aphasia, Wernicke (drug therapy, etiology, pathology)
• Brain (diagnostic imaging, drug effects)
• Donepezil
• Female
• Fluorodeoxyglucose F18 (metabolism)
• Humans
• Image Processing, Computer-Assisted
• Indans (therapeutic use)
• Infarction, Middle Cerebral Artery (complications)
• Magnetic Resonance Imaging
• Middle Aged
• Nootropic Agents (therapeutic use)
• Piperidines (therapeutic use)
• Positron-Emission Tomography